Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

Hims vs Push Health

Hims costs $751 less a month, and both sell semaglutide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
Hims logo

Hims

6.8
★★★☆☆3.4/5

Best for: knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC

Visit Hims →
VS
Push Health logo

Push Health

5.6
★★★☆☆2.8/5

Best for: semaglutide from $950/month

Visit Push Health →

If you are choosing between Hims and Push Health, the first difference is cost: Hims is $751 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Hims leads our six-part score, 6.8 to 5.6. One of the two has an FDA warning letter on record, covered below.

Hims vs Push Health price

Hims is the cheaper way in: $199 a month against $950 a month at Push Health. That is $751 less each month (79% lower), or about $9,012 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Hims ($199 a month vs $950 a month).

Medications and formats

Both sell semaglutide; only Hims lists tirzepatide.

On format, Hims prices compounded injections and brand-name pens, while Push Health prices brand-name pens.

Where each one treats patients

Hims lists 50 states, and Push Health does not publish where it ships.

Pricing

Hims

StartingCompounded
$199/mo
semaglutide
StartingBrand-name
$299/mo
tirzepatide

Brand Zepbound from $299/mo medication-only; requires Hims Weight Loss Membership ($149/mo)

Push Health

PreliminaryBrand-name
$950/mo
semaglutide

Ozempic / brand

What each price covers

Hims' price also covers the medication itself, which Push Health does not claim.

Hims is silent on shipping and lab work.

Push Health does not say what its price includes.

That matters most for the drug: unless Push Health confirms otherwise, budget for medication on top of its listed price.

Hims

Covered by the monthly price

Medication

In the price

Clinician visits

Charged on top

Shipping

Not stated

Lab work

Not stated

Coaching

Charged on top

Push Health

Inclusions not disclosed.

Where each one scores higher

Overall, Hims scores 6.8 and Push Health 5.6 out of 10.

Hims is stronger on effectiveness (10.0 vs 9.0), user experience (8.0 vs 3.0), trust & safety (7.0 vs 4.0) and accessibility (10.0 vs 5.0).

Push Health is stronger on value (5.3 vs 3.0) and support (5.0 vs 3.0).

How we score

Hims

6.8/10

Overall

Push Health

5.6/10

Value25%

3.0A
vs
B
5.3

Effectiveness25%

10.0A
vs
B
9.0

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

7.0A
vs
B
4.0

Accessibility10%

10.0A
vs
B
5.0

Support10%

3.0A
vs
B
5.0

FDA warning letters

The FDA sent Hims a warning letter dated September 9, 2025 (letter 716567), and it is still open.

Push Health has no FDA warning letter on record with us.

Features & Coverage

FeatureHimsPush Health
Starting Price✓$199/mo$950/mo
Features2 features✓5 features
States Available50Not disclosed
Compounded✓ Yes—
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About Hims

Hims is a major men's telehealth brand. Its weight loss offering is compounded semaglutide on a 6-month plan.

Read our full Hims review →

About Push Health

A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.

Read our full Push Health review →

Pros & Cons

Hims

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication
  • Serves all 50 states
  • Names 4 pharmacies that fill its prescriptions, which most sellers do not

Watch-outs

  • Not included in the monthly price: clinician visits, coaching
  • The FDA has issued Hims a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Push Health

What we like

  • Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
  • We found no FDA warning letters issued to Push Health

Watch-outs

  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license

Our Verdict

Winner: Hims

Hims wins this one, 6.8 to 5.6, above all for knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC. It also costs $751 less each month than Push Health. Push Health fits better if semaglutide from $950/month is your priority.

Choose Hims if…

You want knowing which pharmacy fills the vial: it names Apostrophe Pharmacy LLC and an opening price near $199 a month.

Choose Push Health if…

You want semaglutide from $950/month and an opening price near $950 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.6

Breeze Meds

Knowing which pharmacy fills the vial: it names Belmar Pharmacy

7.7

HealthRX

Compounded semaglutide at $133/month

7.3

RNK Health

An oral route if you will not self-inject

Hims vs Push Health: FAQ

Hims. It starts at $199 a month; Push Health starts at $950 a month, $751 more per month.
Yes, both sell semaglutide. Hims adds tirzepatide.
Hims lists 50 states; Push Health does not publish where it ships. Confirm your state before paying.
Only Hims includes the medication itself.
Hims has an open FDA warning letter from September 9, 2025. Push Health has none.
No. Neither Hims nor Push Health pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.